From: medicalnewstoday.com Estimates suggest that about 2.3 million women around the world receive a diagnosis of breast cancer each year. There are currently several treatments available for breast cancer; however, not all treatments work for every person. A new study showcases a new liquid biopsy that can help predict how well patients with advanced breast cancer will respond to targeted …
Switch to Experimental Drug after Liquid Biopsy Detection of Breast Cancer Recurrence Improves Outcomes
From: cornell.edu A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care. The SERENA-6 study, published June 1 in the …
A gentle, cost-effective method for breast cancer diagnosis
Source: Fraunhofer-Gesellschaft From: news-medical.net If breast cancer is suspected, doctors carry out a biopsy. However, this is invasive, painful and costly. It also takes several days to get the results. In the future, diagnosis could be made via a liquid biopsy of a patient’s blood — a gentle, cost-effective method that would deliver the results within just a few hours. …
Spinal fluid analysis could speed up diagnosis of breast cancer spread
From: icr.ac.uk Analysing cancer DNA in spinal fluid could speed up and improve the diagnosis of breast cancer which has spread to the brain and spinal cord, according to a new pilot study. The type of test, known as a liquid biopsy, is more accurate than current methods used to diagnose this type of breast cancer, where it has spread …
Improving Accuracy in Predicting Response to Neoadjuvant Treatment in Patients With Breast Cancer
By: Danielle Garcia From: oncozine.com A liquid biopsy, a sampling and analysis of non-solid biological tissue, primarily blood, is mainly used as a diagnostic and monitoring tool for diseases such as cancer. One of the benefits of liquid biopsies is that they are largely non-invasive. Another advantage is that liquid biopsies may potentially help detect, characterize, and monitor cancers earlier …
Maverick Therapeutics to Use Inivata’s Liquid Biopsy Assay in Phase I/II Clinical Study
By: Staff Reporter 115 From: precisiononcologynews.com Inivata said on Thursday that it has partnered with Maverick Therapeutics to use Inivata’s Radar (Residual Disease and Recurrence) assay to detect and monitor residual disease and recurrence in patients enrolled in Maverick’s Phase I/II clinical study for its MVC-101 drug candidate. As part of the study, the team will use Radar to monitor circulating tumor …
Discovery Life Sciences Launches SpecimenSeq™: Genomically and Clinically Annotated Biospecimen Sets to Speed Liquid Biopsy and Immunotherapy Development
Source: Discovery Life Sciences From: PR Newswire Discovery Life Sciences™ (Discovery) announces the launch of a powerful new tool for liquid biopsy diagnostic assay and oncology drug developers: SpecimenSeq™. SpecimenSeq is a collection of high quality, fully consented biospecimens that include clinical and molecular characterizations to help researchers identify, develop and validate new biomarker signatures for precision medicine applications. SpecimenSeq …
‘Liquid biopsy’ tech contributes to successful clinical trial for detecting breast cancer recurrence
From: purdue.edu Accurately diagnosing the spread of cancer often involves painful and invasive biopsy procedures. The use of a “liquid biopsy,” which involves a simple blood draw, has been shown in a five-year clinical trial to accurately detect and monitor certain kinds of breast cancer. The study involves circulating tumor DNA (ctDNA) and circulating tumor cells (CTC), genetic and cellular …
Liquid biopsy may predict early-stage TNBC recurrence
By: Shreeya Nanda From: medwirenews.com The presence of circulating tumor (ct)DNA and circulating tumor cells (CTCs) in postsurgical samples is associated with relapse and poor outcomes in early-stage triple-negative breast cancer (TNBC) patients with an incomplete pathologic response to neoadjuvant chemotherapy, research suggests. Distant disease-free survival (DDFS), DFS, and overall survival (OS) were significantly worse for patients with versus without …
Some Good News for 2020 for Cancer Survivors
By: Khevin Barnes From: curetoday.com Khevin Barnes is a Male Breast Cancer survivor, magician and speaker. He is currently writing, composing and producing a comedy stage musical about Male Breast Cancer Awareness. He travels wherever he is invited to speak to (and do a little magic for) men and women about breast cancer. www.BreastCancerSpeaker.com www.MaleBreastCancerSurvivor.com I recently spent five amazing …
- Page 1 of 2
- 1
- 2